These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 30544402)
1. Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population. Liu D; Liu X Medicine (Baltimore); 2018 Dec; 97(49):e13358. PubMed ID: 30544402 [TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis. Zhang H; Ge J; Hong H; Bi L; Sun Z World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903 [TBL] [Abstract][Full Text] [Related]
3. Association of ERCC gene polymorphism with osteosarcoma risk. Wang G; Li J; Xu X; Gupta RK; Gao X Afr Health Sci; 2020 Dec; 20(4):1840-1848. PubMed ID: 34394247 [TBL] [Abstract][Full Text] [Related]
4. ERCC polymorphisms and risk of osteosarcoma: a meta-analysis. Chen XJ; Tong ZC; Kang X; Wang ZC; Huang GL; Yang TM; Dong L Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6658-6666. PubMed ID: 30402838 [TBL] [Abstract][Full Text] [Related]
5. Haplotype analysis on relationship of ERCC2 and ERCC3 gene polymorphisms with osteosarcoma risk in Chinese young population. Xu Q; Zhang Z; Sun W; Hu B Mamm Genome; 2017 Jun; 28(5-6):227-233. PubMed ID: 28474168 [TBL] [Abstract][Full Text] [Related]
6. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies. Qian T; Zhang B; Qian C; He Y; Li Y Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298 [TBL] [Abstract][Full Text] [Related]
7. Investigation of ERCC1 and ERCC2 gene polymorphisms and response to chemotherapy and overall survival in osteosarcoma. Zhang Q; Lv LY; Li BJ; Zhang J; Wei F Genet Mol Res; 2015 Sep; 14(3):11235-41. PubMed ID: 26400354 [TBL] [Abstract][Full Text] [Related]
8. ERCC polymorphisms and prognosis of patients with osteosarcoma. Li J; Liu S; Wang W; Zhang K; Liu Z; Zhang C; Chen S; Wu S Tumour Biol; 2014 Oct; 35(10):10129-36. PubMed ID: 25023406 [TBL] [Abstract][Full Text] [Related]
9. Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma. Cao ZH; Yin HP; Jiang N; Yu B Genet Mol Res; 2015 Aug; 14(3):10145-51. PubMed ID: 26345951 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy. Mo J; Luo M; Cui J; Zhou S Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845 [TBL] [Abstract][Full Text] [Related]
11. The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients. Obiedat H; Alrabadi N; Sultan E; Al Shatti M; Zihlif M BMC Med Genet; 2018 Jul; 19(1):112. PubMed ID: 29980176 [TBL] [Abstract][Full Text] [Related]
12. Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy. Liu R; Zhao X; Liu X; Chen Z; Qiu L; Geng R; Guo W; He G; Yin J; Li J; Zhu X Tumour Biol; 2016 Feb; 37(2):1753-62. PubMed ID: 26314858 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma. Sun Y; Wu Y; Li W; Kong Z; Zou X Int J Clin Exp Pathol; 2015; 8(7):7905-12. PubMed ID: 26339355 [TBL] [Abstract][Full Text] [Related]
14. Influence of ABCB-1, ERCC-1 and ERCC-2 gene polymorphisms on response to capecitabine and oxaliplatin (CAPOX) treatment in colorectal cancer (CRC) patients of South India. Varma A; Mathaiyan J; Shewade D; Dubashi B; Sunitha K J Clin Pharm Ther; 2020 Aug; 45(4):617-627. PubMed ID: 32399998 [TBL] [Abstract][Full Text] [Related]
15. Association of ERCC1 and ERCC2 Gene Polymorphisms with Pancreatic Cancer Risk: A Meta-Analysis. Xie F; Sun Q; Zhang E; Mu Y Crit Rev Eukaryot Gene Expr; 2020; 30(3):231-237. PubMed ID: 32749109 [TBL] [Abstract][Full Text] [Related]
16. Letter regarding Li JS et al. entitled "ERCC polymorphisms and prognosis of patients with osteosarcoma". Jian Y; Tian X; Li B; Zhou Z; Wu X Tumour Biol; 2015 May; 36(5):3195-6. PubMed ID: 25824708 [TBL] [Abstract][Full Text] [Related]
17. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma. Wang MJ; Zhu Y; Guo XJ; Tian ZZ Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406 [TBL] [Abstract][Full Text] [Related]
18. Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma. Ji WP; He NB Int J Clin Exp Pathol; 2015; 8(1):894-9. PubMed ID: 25755792 [TBL] [Abstract][Full Text] [Related]
19. Association between common polymorphisms in Li C; Yu X; Guo D; Liu G; Zhang K; Teng Q; Lin H Onco Targets Ther; 2018; 11():3495-3504. PubMed ID: 29950854 [TBL] [Abstract][Full Text] [Related]
20. ERCC1 and ERCC2 variants predict survival in gastric cancer patients. Li Y; Liu Z; Liu H; Wang LE; Tan D; Ajani JA; Wei QY PLoS One; 2013; 8(9):e71994. PubMed ID: 24023723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]